Application 201277

Type
NDA
Sponsor
BAYER HLTHCARE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001GADAVISTGADOBUTROLSOLUTION;INTRAVENOUS4.5354GM/7.5ML (604.72MG/ML)YesYes
002GADAVISTGADOBUTROLSOLUTION;INTRAVENOUS6.0472GM/10ML (604.72MG/ML)YesYes
003GADAVISTGADOBUTROLSOLUTION;INTRAVENOUS9.0708GM/15ML (604.72MG/ML)YesYes
004GADAVISTGADOBUTROLSOLUTION;INTRAVENOUS18.1416GM/30ML (604.72MG/ML)YesYes
005GADAVISTGADOBUTROLSOLUTION;INTRAVENOUS39.3068GM/65ML (604.72MG/ML)YesYes
006GADAVISTGADOBUTROLSOLUTION;INTRAVENOUS1.20944GM/2ML (604.72MG/ML)YesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-325GadavistgadobutrolBayer HealthCare Pharmaceuticals Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85094SUPPL 2026-03-23
85095SUPPL 2026-02-20
85050SUPPL 2026-02-18
81494SUPPL 2025-03-07
81453SUPPL 2025-03-06
79196SUPPL 2024-07-24
79180SUPPL 2024-07-24
77345SUPPL 2024-01-29
77338SUPPL 2024-01-29
71104SUPPL2022-05-20
71103SUPPL2022-05-20
64182SUPPL2020-08-03
64181SUPPL2020-08-03
64152SUPPL2020-07-31
59332SUPPL2019-07-15
59325SUPPL2019-07-12
59324SUPPL2019-07-12
56456SUPPL2018-11-15
56305SUPPL2018-11-06
55038SUPPL2018-07-30
55023SUPPL2018-07-27
55022SUPPL2018-07-27
53909SUPPL2018-05-01
53854SUPPL2018-04-27
18998SUPPL2016-05-05
9874SUPPL2016-04-28
18997SUPPL2015-09-21
9873SUPPL2015-08-03
40057SUPPL2015-01-05
9872SUPPL2014-12-31
9871SUPPL2014-06-12
40056SUPPL2013-10-21
32090SUPPL2013-10-18
9870SUPPL2012-03-26
44833ORIG2011-04-11
22848ORIG2011-04-11
32089ORIG2011-03-16
40055ORIG2011-03-15
66905ORIG1900-01-01
66904ORIG1900-01-01
66903ORIG1900-01-01
54108ORIG1900-01-01
54107ORIG1900-01-01
51135SUPPL1900-01-01
51134SUPPL1900-01-01
51133SUPPL1900-01-01